Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
Beyond the Self and Back: Neuropharmacological Mechanisms Underlying the Dissolution of the Self
University of Zurich
Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators
Johns Hopkins University
Effects and Therapeutic Potential of Psilocybin in Alcohol Dependence
University of New Mexico
Psilocybin and Spiritual Practice
Johns Hopkins University
Psilocybin Cancer Anxiety Study
NYU Langone Health
Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study
Johns Hopkins University
Psychopharmacology of Psilocybin in Cancer Patients
Johns Hopkins University
Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Salivary Oxytocin as a Biomarker of Psychedelic Treatment
University of Geneva, Switzerland
PRoMiSS: Psilocybin and the Role of Music in Set and Setting
Johns Hopkins University
Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)
Cybin IRL Limited
Psilocybin With Intracranial Neural Sensing
Joshua Woolley, MD, PhD
Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant OCD
Centre for Addiction and Mental Health
The Role of Personal Experience for the Therapeutic Attitude in the Context of Substance-assisted Therapy Training
Felix Mueller
Group PACBT for Depression
University of California, Los Angeles
NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy
M.D. Anderson Cancer Center
Psilocybin for Treatment of OCD-2
Francisco A Moreno
The Effects of Psilocybin in Healthy Volunteers: Psychological, Biochemical and Electrophysiological Biomarkers.
Gabriella Gobbi
The Acute Effects of Psilocybin on Cognition, Memory, and Brain Function
Manoj Doss
Redefine Study: A Study Evaluating the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder
COMPASS Pathways
Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence
University of Calgary
Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder
Indiana University
Psilocybin-Assisted Psychotherapy in Treating Irritable Bowel Syndrome (IBS)
NYU Langone Health
Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
VA Office of Research and Development
Psilocybin as a Treatment for Chronic Pain in Smokers
Yale University
Psilocybin Efficacy With or Without Pimavanserin Pretreatment
Johns Hopkins University
Psilocybin After Trauma Surgery for Pain
Trent Emerick
Study of Psilocybin Under Anesthesia Controlled by EEG
Stanford University
Psilocybin as a Novel Therapy for Residual Anhedonia
NYU Langone Health
Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder
Brigham and Women's Hospital
Psilocybin Administration With 5-HT1a Blockade
Johns Hopkins University
Consciousness and Psilocybin Effects on Well-Being: The CoPEWell Study
University of Wisconsin, Madison
Psilocybin-Assisted Therapy as a Treatment for Depression
Washington University School of Medicine
Efficacy in Relapse Prevention: Psilocybin in Alcohol Use Disorder With Depressive Symptoms
Centre Hospitalier Universitaire de Nīmes
Group Retreat Psilocybin Therapy for Healthcare Clinicians With Loss of Meaning in Their Work and Symptoms of Depression
University of Washington
Psilocybin-Assisted Physical Therapy in Chronic Low Back Pain
Yale University
Psilocybin-Assisted Therapy
Emory University
Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring Opioids
Roswell Park Cancer Institute
Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder
Lakshmi N Yatham
Psilocybin-Assisted Cognitive Processing Therapy for Chronic PTSD
Unity Health Toronto
The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease
Yale University
Understanding Music and Mindfulness Preferences in Psilocybin-Assisted Psychotherapy
Kyle Greenway
Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression
Centre for Addiction and Mental Health
Psilocybin AsSisted pSychotherapy for the treatmENt of Gambling disordER : a Pilot Study
Nantes University Hospital
Psilocybin Microdosing on Cognition, Mood and Quality of Life
Yale University
Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder
Centre for Addiction and Mental Health
Effects of Psilocybin on Speech Fluency, Struggle, and Brain Activity in People Who Stutter
NYU Langone Health
Psilocybin for Chronic Pelvic Pain (CPP) in Women: A Pilot Feasibility Study
Oregon Health and Science University
Browse by Condition
View all conditions →How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.